Nurse Practitioner, Family · Oroville, CA
NPI
1568010775
Since 2019
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
2721 Olive Hwy Ste 10b
Oroville, CA, 95966
Phone (530) 532-8687
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$1.2M
6,064 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Marie H Nay prescribed most often to Medicare patients was Lorazepam, with 371 prescriptions and refills. In total Marie H Nay wrote 6,064 Medicare prescriptions that cost $1.2M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-11-22.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Lorazepam Generic | 371 | 373 | 54 | $1,957 |
| Quetiapine Fumarate Generic | 361 | 398 | 42 | $7,707 |
| Clonazepam Generic | 324 | 338 | 45 | $1,317 |
| Duloxetine Hcl Generic | 229 | 284 | 34 | $3,237 |
| Buspirone Hcl Generic | 169 | 195 | 30 | $1,699 |
| Trazodone Hcl Generic | 159 | 204 | 33 | $1,094 |
| Alprazolam Generic | 150 | 150 | 18 | $1,429 |
| Zolpidem Tartrate Generic | 142 | 144 | 19 | $667 |
| Diazepam Generic | 142 | 142 | 11 | $461 |
| Dextroamphetamine-Amphetamine Dextroamphetamine/Amphetamine | 138 | 142 | 17 | $5,137 |
| Lamotrigine Generic | 134 | 175 | 18 | $2,538 |
| Aripiprazole Generic | 131 | 139 | 18 | $11K |
| Bupropion Xl Bupropion Hcl | 127 | 151 | 14 | $2,348 |
| Ziprasidone Hcl Generic | 122 | 174 | Under 11 | $6,006 |
| Fluoxetine Hcl Generic | 120 | 128 | 19 | $601 |
Brand drugs: 659 claims; generic drugs: 5,405 claims; opioid claims: 25.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Marie H Nay were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.